Sabon Nazarin CDC: Alurar riga kafi yana ba da kariya mafi girma fiye da kamuwa da cutar COVID-19 da ta gabata

A yau, CDC ta buga sabon ƙarfafa ilimin kimiyya cewa rigakafin shine mafi kyawun kariya daga COVID-19.A cikin wani sabon MMWR da ke bincikar mutane sama da 7,000 a cikin jihohi 9 waɗanda ke kwance a asibiti tare da rashin lafiya kamar COVID-19, CDC ta gano cewa waɗanda ba a yi musu allurar rigakafi ba kuma suna da kamuwa da cuta na baya-bayan nan sun fi kusan sau 5 fiye da waɗanda aka yi musu cikakken rigakafin kwanan nan. kuma ba shi da kamuwa da cuta a baya.

Bayanan sun nuna cewa allurar rigakafi na iya samar da mafi girma, ƙarfi, da daidaiton matakin rigakafi don kare mutane daga asibiti don COVID-19 fiye da kamuwa da cuta shi kaɗai na aƙalla watanni 6.

“Yanzu muna da ƙarin shaidun da ke sake tabbatar da mahimmancin rigakafin COVID-19, koda kuwa kun taɓa kamuwa da cutar a baya.Wannan binciken yana ƙara ƙarin ga jikin ilimin da ke nuna kariyar rigakafi daga cututtuka masu tsanani daga COVID-19.Hanya mafi kyau don dakatar da COVID-19, gami da bayyanar bambance-bambancen, ita ce tare da yaduwar rigakafin COVID-19 da kuma ayyukan rigakafin cututtuka kamar sanya abin rufe fuska, wanke hannu akai-akai, nisantar jiki, da zama a gida lokacin rashin lafiya, ”in ji Daraktan CDC Dr. Rochelle P. Walensky.

Binciken ya duba bayanai daga cibiyar sadarwa ta VISION wanda ya nuna a tsakanin manya da ke kwance a asibiti tare da alamun COVID-19, mutanen da ba a yi musu allurar riga-kafin cutar a cikin watanni 3-6 sun kasance sau 5.49 mafi kusantar gwajin gwajin COVID-19 fiye da waɗanda suka cika cikakke. allurar rigakafi a cikin watanni 3-6 tare da mRNA (Pfizer ko Moderna) COVID-19 rigakafin.An gudanar da binciken a cikin asibitoci 187.

Alurar rigakafin COVID-19 suna da aminci da tasiri.Suna hana rashin lafiya mai tsanani, asibiti, da mutuwa.CDC ta ci gaba da ba da shawarar duk wanda ya kai shekaru 12 da haihuwa su yi allurar rigakafin COVID-19.